Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | CES2 | O00748 | 2/20 | 0.63 |
| ▸ | CES1 | P23141 | 2/20 | 0.63 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.61 |
| ▸ | ACR | P10323 | 2/20 | 0.61 |
| ▸ | GFER | P55789 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18088853 | 1.00 | KMT2A (0.66) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL27765368 | 1.00 | KMT2A (0.66) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL16429579 | 0.96 | CES2 (0.69) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL18088852 | 0.95 | KMT2A (0.60) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL1546266 | 0.94 | SMN1; SMN2 (0.68) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL7591660 | 0.92 | LMNA (0.75) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL9666088 | 0.92 | LMNA (0.75) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL12633724 | 0.92 | LMNA (0.75) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| SCHEMBL12608584 | 0.92 | LMNA (0.75) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 | |
| Iodobenzene SCHEMBL27765170 | 0.92 | KMT2A (0.57) | KMT2ASMN1; SMN2LMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656927-B2 | Process for the synthesis of carboxylic acid derivatives | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-05-23 | — | — | US | claimed |
| US-20160272554-A1 | PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-09-22 | — | — | US | claimed |
| WO-2015063798-A1 | A PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-05-07 | — | — | WO | claimed |
| JP-63048331-A | — | — | None | — | — | JP | disclosed |
| CN-119708924-A | Ink, ink preparation method and ink-jet printing method | 广东聚华印刷显示技术有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-115724772-A | Compound with urea structure and preparation and application thereof | 云南大学 | 2023-03-03 | — | — | CN | disclosed |
| CN-112110817-B | Method for preparing diaryl ester compound by high-efficiency catalysis of palladium pyridine | 陕西师范大学 | 2022-07-26 | — | — | CN | disclosed |
| CN-112110817-A | Method for preparing diaryl ester compound by high-efficiency catalysis of palladium pyridine | 陕西师范大学 | 2020-12-22 | — | — | CN | disclosed |
| CN-106699717-B | A ring trimethoxy flavone substituted salicylic acid esters compound and its antitumor action | 南华大学 | 2019-04-09 | — | — | CN | disclosed |
| CN-108517022-A | For the ingredient of solid catalyst and its catalyst of olefinic polymerization and application | 北京利和知信科技有限公司 | 2018-09-11 | — | — | CN | disclosed |
| CN-108517021-A | A kind of ingredient of solid catalyst, catalyst and its application being suitable for producing broad molecular weight distribution polymers | 北京利和知信科技有限公司 | 2018-09-11 | — | — | CN | disclosed |
| US-4400543-A | ANTIFERTILITY AGENTS | ELI LILLY AND COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
| US-4361563-A | CARDIOTONIC, ANTITHROMBOTIC | DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1982-11-30 | — | — | US | disclosed |
| EP-0057503-A1 | Production of hydroxy arylophenones | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-08-11 | — | — | EP | disclosed |
| EP-0050497-A1 | Catalyst components for polymerization of alpha-olefins and processes for their preparation and use | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1982-04-28 | — | — | EP | disclosed |
| US-4323707-A | USEFUL FOR AMIMALS, AROYL-PHENYL-NAPHTHALENES OR DIHYDRONAPHTHALENES | ELI LILLY AND COMPANY (US) | 1982-04-06 | — | — | US | disclosed |
| US-4230862-A | 3-PHENYL-4-AROYL-1,2-DIHYDRONAPHTHALENES AND 1-ARYOYL-2-PHENYLNAPHTHALENES | ELI LILLY AND COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-4075223-A | NONSTEROIDAL | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4026891-A | HYPOTENSIVE AGENTS, ANTITHROMBOTICS, AND CARDIOTONICS | BOEHRINGER INGELHEIM GMBH (DT) | 1977-05-31 | — | — | US | disclosed |
| US-4017546-A | AROYL PHENYL INDENES AND AROYL PHENYL NAPHTHALENES | ELI LILLY AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272554-A1 | PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES | PCCA, CPS1, CS | KMT2A 1512/4885SMN1; SMN2 2870/4885LMNA 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.